Loss‐of‐function variants of the filaggrin gene are associated with clinical reactivity to foods

The aim of this study was to assess the genetic association of Filaggrin loss‐of‐function (FLG LOF) genetic variants with food allergy, and to investigate the added value of this test in diagnosing food allergy. Clinical reactivity to foods was diagnosed by the gold standard, the double‐blind, placebo‐controlled food challenge. Of 155 children, 33 (21.3%) children had at least one FLG LOF variant, and of these, 29 (87.9%) were clinically reactive to at least one food, compared to 73 of 122 children (59.8%) carrying wild‐type alleles. The odds ratio for having at least one FLG LOF variant and clinical reactivity to at least one food was 4.9 (CI = 1.6–14.7, P = 0.005), corresponding to a relative risk of 1.5, compared to carriers of wild‐type alleles. Prediction of food allergy improved when FLG LOF variants were included in the model. Therefore, genetic markers may be useful as an addition to clinical assessment in the diagnosis of food allergy.

[1]  C. Flohr,et al.  Atopic dermatitis and disease severity are the main risk factors for food sensitization in exclusively breastfed infants. , 2014, The Journal of investigative dermatology.

[2]  A. Linneberg,et al.  Association between Loss-of-Function Mutations in the Filaggrin Gene and Self-Reported Food Allergy and Alcohol Sensitivity , 2013, International Archives of Allergy and Immunology.

[3]  A. Ponsonby,et al.  Filaggrin loss-of-function mutations do not predict food allergy over and above the risk of food sensitization among infants. , 2012, The Journal of allergy and clinical immunology.

[4]  C. Wijmenga,et al.  Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy , 2011, The Journal of allergy and clinical immunology.

[5]  C. Flohr,et al.  Filaggrin loss‐of‐function mutations are associated with early‐onset eczema, eczema severity and transepidermal water loss at 3 months of age , 2010, The British journal of dermatology.

[6]  Colin N A Palmer,et al.  Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema , 2007, Nature Genetics.

[7]  A. Dubois,et al.  No effects of probiotics on atopic dermatitis in infancy: a randomized placebo‐controlled trial , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[8]  G. Roberts,et al.  Incidence of parentally reported and clinically diagnosed food hypersensitivity in the first year of life. , 2006, The Journal of allergy and clinical immunology.

[9]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[10]  A. Dubois,et al.  Development and validation of challenge materials for double-blind, placebo-controlled food challenges in children. , 2004, The Journal of allergy and clinical immunology.

[11]  Xin Xu,et al.  Implementing a unified approach to family‐based tests of association , 2000, Genetic epidemiology.